Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennon Regulatory News (PNN)

Share Price Information for Pennon (PNN)

Share Price is delayed by 15 minutes
Get Live Data
513.00    9.50 (1.89%)
Bid:
509.00
Ask:
509.50
Spread: 0.50 (0.098%)
Market Cap: £2.42b
PNN Live PriceLast checked at - London Stock Exchange

Intraday Pennon Share Chart

Board Changes

8 Apr 2025 07:00

RNS Number : 0089E
Pennon Group PLC
08 April 2025
 

The Board of Pennon Group Plc (the "Company") is pleased to announce that Andrea Blance has been appointed as a Non-Executive Director and Chair of the Remuneration Committee of the Company with effect from 8 April 2025. 

Andrea brings extensive risk and regulation expertise and is passionate about developing customer focused commercial strategies, following a long career in Financial Services. She is a Non-Executive Director and Risk Committee Chair at Aviva plc and an Advisory Board Member of The Mentoring Foundation.

Andrea spent her executive career at Legal & General Group plc where she held a range of senior leadership roles including Group Chief Risk Officer and Strategy & Marketing Director. More recently, Andrea has been Risk Committee Chair at Hargreaves Lansdown plc, Senior Independent Director and Remuneration Committee Chair of Vanquis Banking Group plc, Senior Independent Director and Audit Committee Chair of ReAssure plc, and Risk Committee Chair of Scottish Widows plc and Lloyds Banking Group Insurance.

Commenting on the appointment, David Sproul, Chair, said, "On behalf of the entire Board, I look forward to welcoming Andrea to Pennon. Her extensive regulatory experience and strong belief in the positive role that businesses should play delivering for customers and communities, and driving sustainable shareholder value, will be invaluable."

Andrea said, "I am absolutely delighted to have been appointed as Remuneration Chair of Pennon. I look forward to working with the Board and a brilliant team of valued colleagues as we look to deliver for customers and all stakeholders, with an enduring positive impact on the environment and society."

The Company confirms that there is no other information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to these appointments.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUBAKRVKUSRAR
Date   Source Headline
25th Jul 20253:31 pmRNSDirector/PDMR Shareholding
25th Jul 20253:30 pmRNSDirector/PDMR Shareholding
24th Jul 20251:48 pmRNSResult of AGM
22nd Jul 20254:00 pmRNSDirector/PDMR Shareholding
11th Jul 202512:03 pmRNSSusan Davy to retire from the Pennon Group Board
10th Jul 20257:05 amRNSUpdate on Ofwat investigation
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
1st Jul 202512:04 pmRNSDirector/PDMR Shareholding
1st Jul 20259:00 amRNSTotal Voting Rights
26th Jun 20257:00 amRNSPublication of Annual Report and Accounts 2025
23rd Jun 202510:42 amRNSDirector/PDMR Shareholding
5th Jun 20253:09 pmRNSEMTN: Publication of Supplementary Prospectus
4th Jun 202510:25 amRNSTotal Voting Rights
3rd Jun 20257:00 amRNSFull Year Results 2024/25
20th May 20254:36 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20259:52 amRNSHolding(s) in Company
23rd Apr 20253:06 pmRNSDirector/PDMR Shareholding
8th Apr 20258:00 amRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSBoard Changes
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSTrading Statement
20th Mar 20251:45 pmRNSDirector/PDMR Shareholding
18th Mar 202511:39 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSCapital Markets Day
7th Mar 20252:55 pmRNSHolding(s) in Company
5th Mar 20259:29 amRNSHolding(s) in Company
3rd Mar 20254:22 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNSTotal Voting Rights
27th Feb 202511:50 amRNSHolding(s) in Company
27th Feb 202511:28 amRNSHolding(s) in Company
27th Feb 202511:26 amRNSHolding(s) in Company
21st Feb 20253:56 pmRNSHolding(s) in Company
21st Feb 20257:00 amRNSHolding(s) in Company
21st Feb 20257:00 amRNSHolding(s) in Company
21st Feb 20257:00 amRNSDirector/PDMR Shareholding
20th Feb 20257:00 amRNSHolding(s) in Company
19th Feb 20253:07 pmRNSHolding(s) in Company
18th Feb 20254:54 pmRNSHolding(s) in Company
18th Feb 202511:38 amRNSResult of Rump Placing
18th Feb 20257:00 amRNSResults of Rights Issue
17th Feb 20251:05 pmRNSHolding(s) in Company
13th Feb 202512:14 pmRNSHolding(s) in Company
12th Feb 20252:53 pmRNSHolding(s) in Company
12th Feb 20252:49 pmRNSHolding(s) in Company
11th Feb 20251:58 pmRNSHolding(s) in Company
10th Feb 202511:50 amRNSHolding(s) in Company
7th Feb 20252:32 pmRNSHolding(s) in Company
7th Feb 202511:45 amRNSEMTN: Publication of Supplementary Prospectus
7th Feb 20259:44 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.